PLoS ONE (Jan 2021)

Correction: Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.

PLOS ONE Staff

Affiliations

PLOS ONE Staff

DOI: https://doi.org/10.1371/journal.pone.0251671
Journal volume & issue: Vol. 16, no. 5
p. e0251671

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0234103.].

Published in PLoS ONE

ISSN: 1932-6203 (Online)
Publisher: Public Library of Science (PLoS)
Country of publisher: United States
LCC subjects: Medicine; Science
Website: https://journals.plos.org/plosone/

About the journal